Trial Profile

Study of PRX 123 for the treatment and prevention of Alzheimer's disease

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 21 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Nov 2024 According to a Prothena media release, companyexpects to update plans for Phase 1 clinical trial in 2025.
08 Aug 2024 According to a Prothena media release, Phase 1 timeline update expected in 2024.
08 May 2024 According to a Prothena media release, company is looking forward to multiple upcoming clinical milestones and program updates over the next 15 months from our wholly-owned programs, including update on timing of the Phase 1 program for PRX123.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com